Anterogen.Co.,Ltd. (KOSDAQ:065660)
South Korea flag South Korea · Delayed Price · Currency is KRW
42,250
-1,650 (-3.76%)
At close: Mar 20, 2026

Anterogen.Co.,Ltd. Revenue

Anterogen.Co.,Ltd. had revenue of 2.04B KRW in the quarter ending September 30, 2025, with 7.39% growth. This brings the company's revenue in the last twelve months to 7.32B, up 5.30% year-over-year. In the year 2024, Anterogen.Co.,Ltd. had annual revenue of 6.93B with 6.66% growth.

Revenue (ttm)
7.32B
Revenue Growth
+5.30%
P/S Ratio
56.09
Revenue / Employee
n/a
Employees
n/a
Market Cap
422.76B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20246.93B432.62M6.66%
Dec 31, 20236.50B-90.76M-1.38%
Dec 31, 20226.59B-1.53B-18.85%
Dec 31, 20218.12B3.97B95.64%
Dec 31, 20204.15B3.67M0.09%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Green Cross Holdings2.40T
EASY BIO,Inc.465.24B
Bioneer320.69B
Medy-Tox241.80B
GC Cell170.13B
BINEX168.47B
JETEMA,75.55B
HLB Therapeutics63.25B
Revenue Rankings